Anne Marieke EZENDAM

Independent Board Member

Advisor, Global Gene Corp (2019-2021)

§Shaping the pharmaceutical business model based on licensing genomics data for drug development, initiate pharma contacts, position for funding

Director, Optimum Strategic Communications


Portfolio Manager and Healthcare Analyst Amundi (2014-2018)

§Responsible for setting up the team’s research platform

Senior Healthcare Analyst, ING IM (2011-2013)

Various roles, Healthcare Investing (1997-2011)

Manager, 3M & Roche (1994-1997)




128 rue de la Boétie, 75008 Paris, France

Press Contacts

Image Sept

Leslie Jung-Isenwater/Sergio de la Calle/Florence Coupry

+33 (0)1 53 70 74 70